What Pill Connect does

Pill Connect Limited is a privately held Manchester-based company that designs and sells a connected pill dispenser and accompanying real-time adherence monitoring software for use in clinical trials. The reusable hardware device attaches to standard 38mm and 33mm medicine bottle neck finishes without requiring primary packaging redesign, dispenses one pill per button press, and uses sensors to confirm and timestamp the actual pill ejection event. Dispensing data is transmitted automatically over Bluetooth via a smartphone app to a remote monitoring platform, eliminating patient-side data entry; when dosing patterns deviate from protocol, the system emails the site team with details for early intervention.

The company's product is built around a two-component system: the Pill Connect Dispenser (hardware with up to 12-month battery life, ISO 8317:2015 child-resistant senior-friendly certification, CE Mark for radio and electrical safety, and ISO 9001 quality management certification) and Real-time Monitoring (software providing continuous per-pill, real-time adherence visibility). Revenue is generated through hardware sales and recurring software/services to pharmaceutical sponsors, biotechs, contract research organizations, and clinical trial sites, with quote-based enterprise pricing and channel partnerships through a global CDMO's smart packaging program and integrations with AARDEX's MEMS AS platform and Aptar Digital Health's SaMD portfolio.

Pill Connect serves the market need for objective, real-time medication adherence data in solid oral dose clinical trials, particularly decentralized and hybrid trial designs and rare disease trials where endpoint protection and early dropout detection carry high economic value. The company holds granted patents in the US, EU, and Japan and has raised funding from the GMC Life Sciences Fund by Praetura and NPIF II Praetura Equity Finance. It remains in early commercial scale-up with 1-10 employees.

Name

Pill Connect

Legal name

Pill Connect Limited

Website

https://pillconnect.com

Company type

Private

Founded year

2017

Operating status

Operating

Headcount range

1–10 employees

Short description

Pill Connect is a Manchester-based company that sells a connected pill dispenser and real-time adherence monitoring software for pharmaceutical sponsors, biotechs, and CROs conducting solid oral dose clinical trials.

Ownership category

akta.pro rank

Product category

Medication Adherence Devices for Clinical Trials

NAICS

Measuring, Dispensing, and Other Pumping Equipment Manufacturing (333914), Totalizing Fluid Meter and Counting Device Manufacturing (334514)

SIC

Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Medication Adherence & Smart Drug Delivery (Connected Inhalers, Pens, Pill Dispensers) (HLACAPAH)

akta.pro secondary industries

Connected Therapeutics & Smart Drug Delivery Monitoring (HLACAFAL), Medication Adherence, Packaging & Fulfillment Services (Blister/Unit-Dose) (HLAFALAJ)

Keywords

• Smart pill dispenser
• Medication adherence monitoring
• Clinical trial adherence
• Connected drug delivery
• Digital health device

Headquarters

HQ city

Manchester

HQ country

United Kingdom

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Personnel, Operations, Supply Chain, Marketing or Sales, Infrastructure

Revenue model

1. Smart dispenser device sales: Sale of reusable smart pill dispenser hardware to pharmaceutical sponsors, CROs, and clinical trial sites for use in medication adherence monitoring during clinical trials.
2. Real-time monitoring software/service: Real-time adherence monitoring platform providing automated alerts and data analytics to site teams during clinical trials. Data transmission and remote monitoring services included.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels4 records

Core offering

Pill Connect designs and sells a reusable smart pill dispenser that attaches to standard oral solid-dose medicine bottles and dispenses one pill per button press, capturing sensor-confirmed, timestamped per-pill dispensing events. A paired real-time monitoring software platform uploads dosing data automatically, applies AI-driven pattern detection, and emails site teams when adherence deviates from protocol, giving pharmaceutical sponsors and CROs objective per-pill adherence data to protect clinical trial endpoints.

Product overview

Pill Connect offers a two-component product system: the Pill Connect Dispenser (a reusable smart hardware device that attaches to standard oral solid dose medicine bottles and dispenses pills with sensor-confirmed timestamp recording) paired with Real-time Monitoring software (cloud-based platform that transmits adherence data automatically and alerts site teams via email when dosing patterns deviate). The dispenser uses Bluetooth to communicate with a smartphone app, which transmits data to remote monitoring platforms. No primary-packaging redesign required; the system fits standard bottles and can be reused by the same patient. The company also provides user manuals available in multiple languages (English, French, Italian, Spanish variants).

Differentiator

Problem solved

Functional benefit

Products and services

• Pill Connect Dispenser A reusable smart pill dispenser that attaches to standard 38mm and 33mm medicine bottles and dispenses one pill per button press, capturing sensor-confirmed timestamped dispensing events. Compatible with capsule sizes 0-5 and a wide range of tablet sizes, with up to 12 months of battery life and ISO 8317:2015 child-resistant senior-friendly certification. Sold to pharmaceutical sponsors, biotech companies, CROs, and clinical trial sites for use in solid oral dose clinical trials and launched drug programs requiring objective adherence data.
• Real-time Monitoring platform Cloud-based real-time adherence monitoring platform that pairs with the Pill Connect Dispenser to transmit dispense data automatically via a smartphone app, monitor dose timing, total daily dose, and protocol adherence, and email alerts to site teams when adherence patterns deviate. Enables early intervention before dropout or efficacy signal dilution in clinical trials, and integrates with adherence platforms such as AARDEX MEMS AS.

Quantifiable outcome

• 99% dispense adherence reported in first clinical proof-of-concept study with TB patients
• +1 more outcomes

Named customers3 records

Segments4 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration2 records

AI capability3 records

Feature6 records

Partnerships

Four partnerships are on record, tiered core.

• AARDEX GroupcoreTechnology or IntegrationStrategic partnership announced August 2025 for multi-cohort Phase 2A dose selection trial. Combines Pill Connect's connected dispenser with AARDEX MEMS AS medication adherence software platform. Joint solution enables centralized real-time adherence monitoring, personalized medication reminders, and dose timing tracking for clinical teams and patients.
• Aptar Digital HealthcoreTechnology or IntegrationCollaboration announced April 2024 for Software as a Medical Device (SaMD) and digital solutions market expansion. Pill Connect to provide accurate dosing data combined with Aptar's digital health platforms for personalized dosing regimens and outcomes-based care.
• UMCG/KFF Clinical Pharmacy and PharmacologycoreStrategic or Co-development PartnerClinical collaboration with University Medical Center Groningen (UMCG) and KFF Clinical Pharmacy and Pharmacology in Netherlands. First clinical proof-of-concept study demonstrating 99% dispense adherence with 10 TB patients over 14 days. Study published in European Respiratory Journal.
• Global CDMO (Contract Development and Manufacturing Organization)coreChannel Partner/ Reseller/ DistributorAccepted onto leading CDMO's smart packaging supply program following intensive validation process. Product passed qualification criteria for operation, robustness, and handling. GMP supplier audits completed, enabling active marketing of technology as ready for clinical trials.

Scale indicators4 records

Recent moves8 records

Expansion highlights6 records

Broad incumbents

• Omnicell: Medication management solutions for hospitals, pharmacies, and patient adherence. Operates adjacent to Pill Connect in the broader medication adherence and packaging ecosystem but at much larger scale and broader scope.
• Aptar Pharma: Global drug delivery device manufacturer (inhalers, injectors, dispensers) and digital health solutions provider. Strategic partner of Pill Connect via Aptar Digital Health for SaMD expansion, and operates in the same drug delivery ecosystem at much larger scale.
• Becton, Dickinson and Company (BD): Large diversified medical device and drug delivery company with pharmaceutical packaging and clinical trial supplies segments. Indirect overlap via Chairman Chris Hall's advisory work with BD and via the broader drug delivery/clinical supply ecosystem.

Direct peers

• Hero Health: Connected automatic pill dispenser with adherence tracking and refill service, primarily serving chronic care patients at home. Comparable hardware category (smart dispenser) but more consumer-focused rather than clinical trial-targeted.
• MedMinder Systems: Connected pill dispenser with reminders, alerts, and adherence reporting, primarily used in home and patient care settings. Comparable in hardware form factor and adherence monitoring use case, though more consumer/patient-direct oriented.
• Vaica Medical: Israel-based provider of medication adherence solutions including smart dispensers and software platforms for clinical trials and patient programs. Comparable as a clinical trial adherence vendor with connected dispenser hardware.
• etectRx: US-based digital health company with an ingestible sensor (ID-Cap) plus smart bottle for per-pill adherence detection. Direct competitor offering per-pill monitoring for clinical trials and patient adherence programs.
• AARDEX Group: Belgium-based medication adherence technology provider offering the MEMS AS software platform and electronic monitoring hardware (caps, bottles). Directly comparable as a clinical-trial adherence vendor and is also a Pill Connect technology partner.
• AdhereTech: US-based maker of smart pill bottles with built-in sensors that track adherence and send reminders. Direct competitor in connected pill dispenser hardware for pharmaceutical and clinical trial use cases.

Emerging players

• Schreiner MediPharm: Pharmaceutical packaging specialist offering smart label-based adherence monitoring (e.g., Bitopertin / Smart Blister concepts). Adjacent rather than direct overlap, but competes for clinical trial packaging and adherence budget.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks3 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/pillconnect

Compliance6 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Pill Connect